Preface |
|
xxi | |
Acknowledgments |
|
xxv | |
Author Bio |
|
xxvii | |
Abbreviations |
|
xxix | |
|
Part I Foundational Aspects of Bio + Electro + Magnetics |
|
|
|
Chapter 1 Foundations of electromagnetism |
|
|
3 | (48) |
|
|
3 | (1) |
|
1.1 Natural and artificial electromagnetic fields |
|
|
3 | (3) |
|
|
3 | (1) |
|
|
4 | (2) |
|
|
6 | (13) |
|
|
6 | (2) |
|
|
8 | (3) |
|
1.2.3 Signals, polarization, and harmonics |
|
|
11 | (1) |
|
1.2.4 Theory of electromagnetic fields |
|
|
12 | (2) |
|
1.2.5 Electromagnetic waves |
|
|
14 | (1) |
|
|
14 | (2) |
|
1.2.5.2 Wave-particle duality |
|
|
16 | (1) |
|
1.2.5.3 Near-, intermediate-, and far-field regions |
|
|
16 | (1) |
|
1.2.5.4 Electromagnetic fields |
|
|
17 | (2) |
|
1.3 Electromagnetic induction |
|
|
19 | (2) |
|
1.4 Electromagnetic energy |
|
|
21 | (1) |
|
1.5 Electromagnetic spectrum |
|
|
22 | (2) |
|
1.6 Sources of electric and magnetic fields |
|
|
24 | (6) |
|
|
24 | (1) |
|
|
25 | (1) |
|
1.6.1.2 Magnetic resonance imaging (MRI) |
|
|
26 | (1) |
|
|
26 | (1) |
|
|
27 | (1) |
|
1.6.2.1 Single-conductor source |
|
|
28 | (1) |
|
1.6.2.2 Dual-conductor source |
|
|
28 | (1) |
|
|
29 | (1) |
|
1.6.2.4 Three-phase source |
|
|
29 | (1) |
|
1.7 Sources of radiofrequency radiation |
|
|
30 | (9) |
|
1.7.1 Wireless frequency allocations |
|
|
30 | (2) |
|
|
32 | (1) |
|
|
32 | (1) |
|
1.7.3.1 Transmission lines |
|
|
32 | (1) |
|
|
33 | (1) |
|
|
34 | (1) |
|
|
34 | (1) |
|
1.7.4.1 Antenna properties |
|
|
35 | (2) |
|
1.7.4.2 Types of antennas |
|
|
37 | (2) |
|
1.8 Fifth generation (5G) wireless systems |
|
|
39 | (9) |
|
1.8.1 Millimeter wave (MMW) communications |
|
|
40 | (2) |
|
|
42 | (1) |
|
1.8.3 Soft and green network |
|
|
43 | (1) |
|
1.8.3.1 Radio Access Network (RAN) |
|
|
43 | (1) |
|
|
44 | (1) |
|
|
45 | (1) |
|
1.8.4 Satellite and non-terrestrial networks |
|
|
46 | (1) |
|
|
47 | (1) |
|
1.8.6 The questions of electromagnetic constraint |
|
|
47 | (1) |
|
|
48 | (3) |
|
Chapter 2 Foundations of bioelectromagnetics |
|
|
51 | (46) |
|
|
51 | (1) |
|
|
51 | (2) |
|
2.2 Biophysical aspects of bioelectromagnetics |
|
|
53 | (11) |
|
2.2.1 Interaction mechanisms for electric and magnetic fields |
|
|
54 | (1) |
|
2.2.1.1 Induced fields and currents |
|
|
54 | (2) |
|
2.2.1.2 Electrostimulation |
|
|
56 | (1) |
|
2.2.1.3 Magnetic biosubstances |
|
|
57 | (1) |
|
|
58 | (1) |
|
2.2.2 Interaction mechanisms for radio frequency radiation |
|
|
58 | (1) |
|
2.2.2.1 Thermal mechanisms |
|
|
58 | (2) |
|
2.2.2.2 Nonthermal/athermal mechanisms |
|
|
60 | (1) |
|
2.2.2.3 Thermal- or nonthermal-based exposure limits? |
|
|
61 | (1) |
|
2.2.3 Cell membrane and the chemical link |
|
|
62 | (1) |
|
2.2.3.1 The role of cell membranes |
|
|
62 | (1) |
|
2.2.3.2 Voltage-gated calcium channels (VGCCs) |
|
|
63 | (1) |
|
2.3 Biological and health effects |
|
|
64 | (12) |
|
2.3.1 Cells and membranes |
|
|
65 | (1) |
|
|
66 | (1) |
|
2.3.3 Changes in protein conformation |
|
|
67 | (1) |
|
2.3.4 Changes in binding probability |
|
|
67 | (1) |
|
2.3.5 Vibrational states of biological components |
|
|
68 | (1) |
|
|
68 | (1) |
|
|
69 | (1) |
|
2.3.8 Hypothesis of melatonin |
|
|
70 | (2) |
|
|
72 | (1) |
|
2.3.10 Brain and nervous system |
|
|
72 | (2) |
|
|
74 | (1) |
|
2.3.10.2 Neurological effects |
|
|
75 | (1) |
|
2.4 Bioelectromagnetic dosimetry |
|
|
76 | (10) |
|
|
77 | (1) |
|
2.4.1.1 Induced current density |
|
|
77 | (1) |
|
2.4.1.2 Specific absorption rate |
|
|
78 | (2) |
|
|
80 | (1) |
|
2.4.1.4 Exposure-ratio metric |
|
|
81 | (1) |
|
|
81 | (1) |
|
|
81 | (1) |
|
2.4.1.7 Thermal dosimetry |
|
|
82 | (2) |
|
|
84 | (1) |
|
2.4.3 Impact of frequency |
|
|
85 | (1) |
|
2.4.4 Impact of dielectric constant |
|
|
86 | (1) |
|
2.5 Toward health-based safety standards |
|
|
86 | (1) |
|
|
87 | (10) |
|
Part II Extremely Low Frequency Fields |
|
|
|
Chapter 3 Extremely low frequency field safety |
|
|
97 | (42) |
|
|
97 | (1) |
|
|
97 | (2) |
|
3.2 Safety standards and guidelines |
|
|
99 | (9) |
|
3.2.1 Standardization process |
|
|
99 | (2) |
|
|
101 | (1) |
|
|
102 | (2) |
|
|
104 | (1) |
|
3.2.5 Precautionary exposure models |
|
|
105 | (3) |
|
|
108 | (3) |
|
|
108 | (1) |
|
|
109 | (1) |
|
3.3.3 Transportation systems |
|
|
110 | (1) |
|
|
111 | (2) |
|
3.5 Measurement techniques |
|
|
113 | (6) |
|
3.5.1 Electric field measurements |
|
|
114 | (1) |
|
3.5.2 Magnetic field measurements |
|
|
115 | (2) |
|
3.5.3 Test and survey protocol |
|
|
117 | (2) |
|
3.6 Exposure assessments and exposimetry |
|
|
119 | (4) |
|
3.6.1 Outdoor and indoor environmental surveys |
|
|
119 | (1) |
|
3.6.2 Residential exposure |
|
|
120 | (1) |
|
3.6.3 Transport systems exposure |
|
|
121 | (1) |
|
3.6.4 Personal exposimetry |
|
|
122 | (1) |
|
|
123 | (9) |
|
3.7.1 Mitigation techniques |
|
|
123 | (1) |
|
|
123 | (1) |
|
|
123 | (2) |
|
3.7.1.3 Electric vehicles |
|
|
125 | (1) |
|
3.7.2 Shielding techniques |
|
|
125 | (1) |
|
|
126 | (1) |
|
3.7.2.2 Passive shielding by conductive materials |
|
|
127 | (1) |
|
3.7.2.3 Passive shielding by ferromagnetic materials |
|
|
128 | (1) |
|
|
129 | (1) |
|
3.7.3 Reduction procedures |
|
|
130 | (1) |
|
|
130 | (1) |
|
|
131 | (1) |
|
|
132 | (7) |
|
Chapter 4 Health effects of exposure to extremely low frequency fields |
|
|
139 | (38) |
|
|
139 | (1) |
|
|
139 | (1) |
|
4.2 Epidemiological studies |
|
|
140 | (9) |
|
4.2.1 Occupational environments |
|
|
142 | (1) |
|
4.2.2 General public environments |
|
|
143 | (1) |
|
4.2.2.1 Childhood cancer and leukemia |
|
|
144 | (1) |
|
|
145 | (2) |
|
4.2.2.3 Neurodegenerative diseases |
|
|
147 | (1) |
|
4.2.2.4 Reproductive health effects |
|
|
147 | (2) |
|
4.2.3 Summary of epidemiological studies |
|
|
149 | (1) |
|
|
149 | (5) |
|
4.3.1 Genotoxicity and carcinogenicity |
|
|
149 | (2) |
|
|
151 | (1) |
|
|
152 | (2) |
|
|
154 | (5) |
|
|
155 | (1) |
|
|
155 | (1) |
|
4.4.3 Cardiovascular system |
|
|
156 | (1) |
|
|
157 | (1) |
|
4.4.5 Reproductive and development effect |
|
|
158 | (1) |
|
|
159 | (2) |
|
|
160 | (1) |
|
|
161 | (1) |
|
|
161 | (16) |
|
Part III Radio Frequency Radiation |
|
|
|
Chapter 5 Radio frequency radiation safety |
|
|
177 | (48) |
|
|
177 | (1) |
|
|
177 | (1) |
|
|
178 | (11) |
|
5.2.1 Process of standardization |
|
|
178 | (2) |
|
5.2.2 IEEE C95.1 standard |
|
|
180 | (2) |
|
5.2.3 Federal Communication Commission (FCC) guidelines |
|
|
182 | (1) |
|
|
183 | (2) |
|
5.2.5 Compliances and restrictions |
|
|
185 | (2) |
|
5.2.6 Precautionary exposure models |
|
|
187 | (2) |
|
|
189 | (9) |
|
5.3.1 Whole-body assessments |
|
|
189 | (2) |
|
5.3.2 In-head assessments |
|
|
191 | (1) |
|
5.3.2.1 Sources of local RFR |
|
|
192 | (2) |
|
|
194 | (1) |
|
|
195 | (1) |
|
5.3.3 Tissue and skin dosimetry |
|
|
196 | (2) |
|
5.4 Exposure assessment and exposimetry |
|
|
198 | (13) |
|
5.4.1 Exposure assessment approaches |
|
|
198 | (1) |
|
5.4.1.1 Assessment techniques |
|
|
199 | (1) |
|
|
200 | (1) |
|
5.4.2 Sources of environmental RFR |
|
|
200 | (1) |
|
5.4.2.1 Cellular base stations |
|
|
200 | (3) |
|
5.4.2.2 Broadcast antennas |
|
|
203 | (1) |
|
5.4.2.3 Wireless internet |
|
|
204 | (1) |
|
5.4.2.4 Bluetooth devices |
|
|
204 | (1) |
|
5.4.2.5 Smart electricity meters |
|
|
205 | (1) |
|
5.4.2.6 Baby monitoring systems |
|
|
205 | (1) |
|
5.4.2.7 Microwave ovens, heaters, and dryers |
|
|
205 | (1) |
|
5.4.2.8 Medical equipment |
|
|
206 | (1) |
|
|
206 | (1) |
|
5.4.3 Indoor environmental RFR |
|
|
206 | (1) |
|
5.4.3.1 Exposure in public places |
|
|
207 | (1) |
|
5.4.3.2 Exposures in residential places |
|
|
208 | (1) |
|
5.4.3.3 Exposures in transportation facilities |
|
|
209 | (1) |
|
5.4.3.4 Summary of results |
|
|
209 | (1) |
|
5.4.4 Outdoor environmental RFR |
|
|
210 | (1) |
|
5.5 Mitigation approaches |
|
|
211 | (2) |
|
5.5.1 Exposure from common sources |
|
|
211 | (1) |
|
|
211 | (2) |
|
|
213 | (4) |
|
5.6.1 Harmonizing exposure limits |
|
|
213 | (2) |
|
5.6.2 5G deployment policies |
|
|
215 | (1) |
|
5.6.3 Dosimetry knowledge gap |
|
|
215 | (2) |
|
|
217 | (8) |
|
Chapter 6 Health effects of exposure to radio frequency radiation |
|
|
225 | (44) |
|
|
225 | (1) |
|
|
225 | (1) |
|
6.2 Epidemiological studies |
|
|
226 | (4) |
|
6.2.1 Occupational exposure studies |
|
|
226 | (1) |
|
6.2.2 Public exposure studies |
|
|
227 | (1) |
|
|
228 | (1) |
|
|
229 | (1) |
|
|
230 | (1) |
|
6.3 Cellular and animal studies |
|
|
230 | (4) |
|
|
230 | (2) |
|
|
232 | (1) |
|
|
233 | (1) |
|
|
234 | (3) |
|
6.4.1 Perception and auditory response |
|
|
234 | (1) |
|
|
235 | (1) |
|
|
236 | (1) |
|
|
237 | (1) |
|
|
237 | (1) |
|
6.5 Reproductive system and male fertility |
|
|
237 | (2) |
|
6.5.1 State of the art review |
|
|
238 | (1) |
|
6.5.2 Protective measures |
|
|
238 | (1) |
|
6.6 Electromagnetic hypersensitivity (EHS) |
|
|
239 | (4) |
|
6.6.1 Sensitivity of children |
|
|
239 | (1) |
|
6.6.2 Hypersensitivity of adults |
|
|
240 | (3) |
|
|
243 | (6) |
|
6.7.1 International and national expert group evaluations |
|
|
243 | (1) |
|
6.7.1.1 International Agency for Research on Cancer (IARC) |
|
|
243 | (1) |
|
6.7.1.2 Bio-Initiatives Working Group |
|
|
244 | (1) |
|
6.7.1.3 Committee on Man and Radiation (COMAR) |
|
|
244 | (1) |
|
6.7.1.4 World Health Organization (WHO) |
|
|
244 | (1) |
|
6.7.1.5 French Agency for Food, Environmental and Occupational Health and Safety (ANSES) |
|
|
245 | (1) |
|
6.7.1.6 Advisory Group on Non-ionizing Radiation (AGNIR) |
|
|
245 | (1) |
|
6.7.1.7 Norwegian Institute of Public Health |
|
|
245 | (1) |
|
6.7.1.8 Swedish Council for Working Life and Social Research (SCWLSR) |
|
|
245 | (1) |
|
6.7.1.9 Institute of Engineering and Technology (IET) |
|
|
246 | (1) |
|
6.7.1.10 Expert Panel report on a review of Safety Code 6 |
|
|
246 | (1) |
|
6.7.1.11 Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) |
|
|
247 | (1) |
|
6.7.1.12 Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) |
|
|
247 | (1) |
|
6.7.1.13 National Toxicology Program (NTP) |
|
|
248 | (1) |
|
|
248 | (1) |
|
|
249 | (20) |
|
Part IV Therapeutic Applications |
|
|
|
Chapter 7 Diathermy therapy |
|
|
269 | (36) |
|
|
269 | (1) |
|
|
269 | (4) |
|
7.1.1 Historical perspective |
|
|
269 | (3) |
|
|
272 | (1) |
|
|
273 | (4) |
|
|
273 | (1) |
|
|
274 | (1) |
|
|
275 | (2) |
|
7.3 Therapeutic categories |
|
|
277 | (2) |
|
|
279 | (2) |
|
7.4.1 Short-wave diathermy |
|
|
279 | (1) |
|
7.4.2 Microwave diathermy |
|
|
280 | (1) |
|
7.4.3 MMW and THz therapy |
|
|
281 | (1) |
|
7.5 Diathermy therapeutic applications |
|
|
281 | (4) |
|
|
281 | (2) |
|
7.5.2 Rehabilitation practice |
|
|
283 | (1) |
|
7.5.3 Bone and tissue healing |
|
|
284 | (1) |
|
7.6 Possible side effects of EM energy and heat |
|
|
285 | (7) |
|
7.6.1 Tissue physiology and response to heat |
|
|
285 | (1) |
|
|
286 | (1) |
|
7.6.3 Immunological effects |
|
|
287 | (1) |
|
7.6.4 Cardiovascular responses |
|
|
288 | (1) |
|
7.6.5 Nervous system responses |
|
|
289 | (2) |
|
7.6.6 Carcinogenic effects |
|
|
291 | (1) |
|
|
292 | (2) |
|
|
292 | (1) |
|
7.7.2 Trends in equipment development |
|
|
293 | (1) |
|
|
294 | (1) |
|
|
294 | (11) |
|
Chapter 8 Hyperthermia therapy |
|
|
305 | (52) |
|
|
305 | (1) |
|
|
305 | (6) |
|
8.1.1 Historical perspective |
|
|
305 | (1) |
|
8.1.2 Early research work |
|
|
306 | (1) |
|
8.1.3 Modern hyperthermia |
|
|
307 | (2) |
|
8.1.4 Practical challenges |
|
|
309 | (1) |
|
8.1.5 A wealth of literature |
|
|
310 | (1) |
|
8.2 Biophysical and practical rationale |
|
|
311 | (3) |
|
|
311 | (2) |
|
|
313 | (1) |
|
|
314 | (1) |
|
8.3 Hyperthermia in oncology |
|
|
314 | (8) |
|
|
315 | (1) |
|
8.3.1.1 External local hyperthermia |
|
|
316 | (1) |
|
8.3.1.2 Intraluminal local hyperthermia |
|
|
316 | (1) |
|
8.3.1.3 Interstitial local hyperthermia |
|
|
317 | (1) |
|
8.3.2 Regional hyperthermia |
|
|
318 | (1) |
|
8.3.2.1 Deep regional hyperthermia |
|
|
318 | (1) |
|
8.3.2.2 Regional perfusion hyperthermia |
|
|
319 | (1) |
|
8.3.2.3 Local regional hyperthermia or oncothermia |
|
|
319 | (1) |
|
8.3.3 Whole-Body Hyperthermia (WBH) |
|
|
320 | (1) |
|
8.3.4 Extracellular hyperthermia |
|
|
321 | (1) |
|
8.4 Hyperthermia techniques and equipment |
|
|
322 | (10) |
|
|
322 | (1) |
|
8.4.1.1 Radio frequency (RF) |
|
|
322 | (1) |
|
|
323 | (1) |
|
8.4.2 External RF applicators |
|
|
324 | (1) |
|
8.4.2.1 Capacitive heating |
|
|
324 | (1) |
|
8.4.2.2 Inductive heating |
|
|
325 | (1) |
|
8.4.2.3 Hybrid heating systems |
|
|
326 | (1) |
|
8.4.3 External radiative EM devices |
|
|
326 | (1) |
|
8.4.3.1 Single applicators |
|
|
327 | (1) |
|
8.4.3.2 Multielement array applicators |
|
|
328 | (2) |
|
8.4.4 Interstitial and intracavitary devices |
|
|
330 | (1) |
|
8.4.5 Nanotechnology-based sources |
|
|
331 | (1) |
|
8.5 Hyperthermia with other modalities |
|
|
332 | (3) |
|
8.5.1 Hyperthermia and radiation |
|
|
333 | (1) |
|
8.5.2 Hyperthermia and chemotherapy |
|
|
334 | (1) |
|
8.5.3 Hyperthermia and radiochemotherapy |
|
|
335 | (1) |
|
|
335 | (2) |
|
8.6.1 Technical and clinical challenges |
|
|
335 | (2) |
|
|
337 | (1) |
|
|
337 | (1) |
|
|
338 | (19) |
|
Chapter 9 Ablation therapy |
|
|
357 | (52) |
|
|
357 | (1) |
|
|
357 | (1) |
|
9.2 Procedures and techniques |
|
|
358 | (2) |
|
9.2.1 Minimally invasive procedures |
|
|
358 | (1) |
|
9.2.2 Ablation techniques |
|
|
359 | (1) |
|
9.3 Clinical applications |
|
|
360 | (4) |
|
|
361 | (1) |
|
|
361 | (1) |
|
|
362 | (1) |
|
|
362 | (1) |
|
|
363 | (1) |
|
|
363 | (1) |
|
|
363 | (1) |
|
9.4 Radio frequency ablation (RFA) |
|
|
364 | (11) |
|
9.4.1 Technical considerations |
|
|
364 | (1) |
|
|
364 | (1) |
|
9.4.1.2 Electrodes and approaches |
|
|
365 | (1) |
|
9.4.1.3 Multiple applicators |
|
|
366 | (1) |
|
|
367 | (1) |
|
9.4.1.5 Thermal-electrical modeling |
|
|
368 | (1) |
|
9.4.2 Clinical advantages and applications |
|
|
368 | (1) |
|
|
369 | (2) |
|
|
371 | (1) |
|
9.4.2.3 Snoring and obstructive sleep apnea (OSA) |
|
|
372 | (1) |
|
|
373 | (1) |
|
|
374 | (1) |
|
9.5 Microwave ablation (MWA) |
|
|
375 | (9) |
|
9.5.1 Technical considerations |
|
|
376 | (1) |
|
|
376 | (1) |
|
|
377 | (1) |
|
9.5.1.3 Multiple insertions and multiple antennas |
|
|
378 | (1) |
|
9.5.2 Clinical advantages and applications |
|
|
379 | (1) |
|
|
379 | (1) |
|
|
380 | (1) |
|
9.5.2.3 Microwave endometrial ablation (MEA) |
|
|
381 | (2) |
|
|
383 | (1) |
|
|
384 | (1) |
|
9.6 Trends and future research |
|
|
384 | (3) |
|
9.6.1 Improved techniques |
|
|
384 | (2) |
|
9.6.2 Ablation in clinical practice |
|
|
386 | (1) |
|
|
386 | (1) |
|
|
387 | (22) |
|
Part V Dosimetry, Thermometry, and Medical Imaging |
|
|
|
Chapter 10 Electromagnetic-thermal dosimetry |
|
|
409 | (24) |
|
|
409 | (1) |
|
|
409 | (1) |
|
10.2 Power deposition modeling |
|
|
410 | (2) |
|
10.2.1 Techniques for low frequencies |
|
|
410 | (1) |
|
10.2.2 Techniques for radiofrequency radiation |
|
|
411 | (1) |
|
10.2.2.1 Analytical techniques |
|
|
411 | (1) |
|
10.2.2.2 Numerical techniques |
|
|
411 | (1) |
|
10.3 Thermoregulatory modeling |
|
|
412 | (2) |
|
|
412 | (1) |
|
10.3.2 Thermal measurements |
|
|
413 | (1) |
|
10.4 Bioheat transfer models |
|
|
414 | (7) |
|
|
415 | (2) |
|
|
417 | (1) |
|
|
418 | (1) |
|
10.4.4 Weinbaum-Jiji model |
|
|
418 | (2) |
|
|
420 | (1) |
|
10.4.6 Applications of bioheat transfer models |
|
|
420 | (1) |
|
10.5 Thermal therapy planning system (TTPS) |
|
|
421 | (3) |
|
10.5.1 Objectives and requirements |
|
|
421 | (2) |
|
10.5.2 Developments in TTPS |
|
|
423 | (1) |
|
|
423 | (1) |
|
|
424 | (1) |
|
|
425 | (8) |
|
Chapter 11 Thermometry and medical imaging |
|
|
433 | (34) |
|
|
433 | (1) |
|
|
433 | (1) |
|
11.2 Historical perspective |
|
|
434 | (1) |
|
11.3 Invasive thermometry |
|
|
435 | (3) |
|
11.3.1 Thermoelectric thermometry |
|
|
436 | (1) |
|
|
437 | (1) |
|
|
437 | (1) |
|
|
438 | (1) |
|
11.4 Non-invasive thermometry and imaging techniques |
|
|
438 | (17) |
|
11.4.1 Ultrasound imaging |
|
|
440 | (1) |
|
|
440 | (1) |
|
11.4.1.2 Advantages and limitations |
|
|
441 | (1) |
|
11.4.1.3 Two-to three-dimensional ultrasonography |
|
|
442 | (1) |
|
11.4.2 Magnetic resonance imaging (MRI) |
|
|
443 | (1) |
|
|
443 | (2) |
|
11.4.2.2 Advantages and limitations |
|
|
445 | (1) |
|
|
446 | (2) |
|
|
448 | (1) |
|
11.4.4.1 Characteristics of THz radiation |
|
|
448 | (1) |
|
|
449 | (2) |
|
|
451 | (1) |
|
11.4.4.4 THz-ray computed tomography (CT) |
|
|
451 | (1) |
|
|
452 | (1) |
|
11.4.6 X-ray computed tomography |
|
|
453 | (1) |
|
11.4.6.1 Conventional CT scanners |
|
|
454 | (1) |
|
11.4.6.2 Spiral (helical) CT scanners |
|
|
454 | (1) |
|
11.4.6.3 Multislice CT scanners |
|
|
455 | (1) |
|
|
455 | (1) |
|
|
456 | (11) |
|
Chapter 12 Electromagnetic risk paradigm |
|
|
467 | (28) |
|
|
467 | (1) |
|
|
467 | (2) |
|
|
469 | (5) |
|
12.2.1 Scientific evidence |
|
|
470 | (2) |
|
12.2.2 Safety standard programs |
|
|
472 | (1) |
|
12.2.3 Structured risk assessment |
|
|
473 | (1) |
|
|
474 | (3) |
|
12.3.1 Public perception of risk |
|
|
474 | (1) |
|
12.3.2 Factors relevant to electromagnetic fields |
|
|
475 | (1) |
|
12.3.3 Health consequences of risk perception |
|
|
476 | (1) |
|
|
477 | (5) |
|
12.4.1 Anticipatory ethics |
|
|
477 | (1) |
|
12.4.2 Involving the public |
|
|
478 | (1) |
|
|
479 | (1) |
|
12.4.4 Precautionary approaches |
|
|
479 | (3) |
|
12.4.5 Public understanding of precautionary actions |
|
|
482 | (1) |
|
|
482 | (5) |
|
12.5.1 Role of communication in risk assessment |
|
|
484 | (1) |
|
|
485 | (1) |
|
|
485 | (1) |
|
12.5.4 Role of the internet |
|
|
486 | (1) |
|
12.5.5 Communication with children |
|
|
487 | (1) |
|
12.6 Trends and future research |
|
|
487 | (4) |
|
12.6.1 Challenges and implications |
|
|
487 | (1) |
|
12.6.2 Research and policy |
|
|
488 | (2) |
|
12.6.3 Concluding remarks |
|
|
490 | (1) |
|
|
491 | (4) |
Index |
|
495 | |